August 2017 Price Concessions/NCSO


August 2017 Price Concessions/NCSO

August 10, 2017

The Department of Health has granted the following price concessions for August 2017:

Drug Pack size Price concession
Betahistine 16mg tablets 84 £11.05
Betahistine 8mg tablets 84 £6.33
Buspirone 10mg tablets 30 £9.00
Dapsone 50mg tablets 28 £44.50
Diamorphine 30mg powder for solution for injection ampoules 5 £16.52
Exemestane 25mg tablets 30 £63.50
Levetiracetam 1g tablets 60 £95.34
Levetiracetam 250mg tablets 60 £28.01
Levetiracetam 500mg tablets 60 £49.32
Levetiracetam 750mg tablets 60 £61.50
Mefenamic acid 500mg tablets 28 £55.00
Olanzapine 10mg tablets 28 £65.00
Olanzapine 15mg tablets 28 £85.00
Olanzapine 2.5mg tablets 28 £16.75
Olanzapine 20mg tablets 28 £110.00
Olanzapine 5mg tablets 28 £33.25
Olanzapine 7.5mg tablets 28 £65.00
Oxazepam 10mg tablets 28 £19.97
Oxazepam 15mg tablets 28 £19.97
Pramipexole 88mcg tablets 30 £13.50
Quetiapine 100mg tablets 60 £90.48
Quetiapine 200mg tablets 60 £90.48
Quetiapine 25mg tablets 60 £27.06
Rizatriptan 10mg tablets 3 £13.37
Sodium cromoglicate 2% eye drops 13.5ml £9.72
Sumatriptan 100mg tablets 6 £32.00
Sumatriptan 50mg tablets 6 £28.00
Tranexamic acid 500mg tablets 60 £14.30
Valsartan 160mg capsules 28 £12.00
Valsartan 40mg capsules 28 £7.70
Valsartan 80mg capsules 28 £9.99
Zolmitriptan 2.5mg orodispersible tablets sugar free 6 £17.90
Zolmitriptan 2.5mg tablets 6 £18.00

The price concession only applies to the month that it is granted.

Please note negotiations are still ongoing regarding a number of products.

Contractors will be alerted to any updates through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of generic products that are suspected of being affected by generic supply problems unless and until the Department of Health grants a concession. No additional endorsements are required for price concessions.

If you have problems obtaining a Part VIII product or problems obtaining the product at the set Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.

If you have been able to source the product, please provide full details of the supplier and price paid. PSNC will investigate the extent of the problem and if appropriate discuss the issue with the Department of Health.

Any further concessions will be posted here on the website.

Posted in:

More Latest News >

Name change for Appeals Unit

From 2nd July 2018, the Family Health Services Appeal Unit (or FHSAU) has been renamed as the Primary Care Appeals...

CPPE launches GDPR e-learning

The Centre for Pharmacy Postgraduate Education (CPPE) has published a General Data Protection Regulation (GDPR) e-learning programme for pharmacy professionals....

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and...